Cunniff James L. sold $354K of ELMD
Cunniff James L. (CEO and President) sold 9,700 shares of Electromed, Inc. (ELMD) at an average of $36.50 ($36.25–$37.77, $0.35M total) across 3 trades on 2026-06-08.
Electromed, Inc.
No enriched coverage for $ELMD in the last 7 days.
No SEC Form 4 filings for $ELMD in the last 30 days.
See all $ELMD insider activity →Cunniff James L. (CEO and President) sold 9,700 shares of Electromed, Inc. (ELMD) at an average of $36.50 ($36.25–$37.77, $0.35M total) across 3 trades on 2026-06-08.
Nagel Bradley M. (Chief Financial Officer) sold 11,801 shares of Electromed, Inc. (ELMD) at an average of $36.35 ($36.34–$37.11, $0.43M total) across 2 trades on 2026-06-04.
NULL
Recent ELMD coverage spans financial news and insider activity.
This is a routine insider sale with no stated 10b5-1 plan, but it does not disclose new company fundamentals.
This is a routine insider sale with no stated operational or financial catalyst, so near-term price impact is likely limited.
Recent insider selling of Electromed (ELMD) shares worth approximately $1.42 million indicates potential insider caution, aligning with bearish sentiment.
The filing suggests an upcoming share sale by Electromed, Inc., which could exert mild downward pressure on the stock price due to increased supply.
Electromed (ELMD) is positioned as a solid growth stock with potential for exceptional returns based on recent growth attributes.
alphai scores every news story that mentions ELMD with an AI model for sentiment and relevance, and aggregates insider trades from Electromed, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cunniff James L. (CEO and President) sold 9,700 shares of Electromed, Inc. (ELMD) at an average of $36.50 ($36.25–$37.77, $0.35M total) across 3 trades on 2026-06-08.
2 min readNagel Bradley M. (Chief Financial Officer) sold 11,801 shares of Electromed, Inc. (ELMD) at an average of $36.35 ($36.34–$37.11, $0.43M total) across 2 trades on 2026-06-04.
1 min readThis article details an SEC Form 144 filing by Electromed, Inc. (ELMD) concerning a proposed sale of 40,000 shares of common stock with an aggregate market value of $1,419,357.79. The securities were acquired via an option grant on July 1, 2016, and are intended for sale on May 15, 2026, through Fidelity Brokerage Services. The filing indicates a neutral impact and sentiment.
2 min readElectromed (ELMD) could produce exceptional returns because of its solid growth attributes.
3 min readElectromed (ELMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
2 min readThe consensus price target hints at a 39.2% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
2 min readElectromed (ELMD) delivered earnings and revenue surprises of +13.64% and +1.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
2 min readLet's take a look at four stocks, AVO, ELMD, GLDD and CENX, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
3 min readDoes Electromed, Inc. (ELMD) have what it takes to be a top stock pick for momentum investors? Let's find out.
3 min read